[Federal Register Volume 61, Number 216 (Wednesday, November 6, 1996)]
[Notices]
[Pages 57436-57438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28502]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-97-28]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Wilma Johnson, CDC 
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 
30333. Written comments should be received within 60 days of this 
notice.

Proposed Projects

    1. The National Home and Hospice Care Survey (NHHCS)--(0920-0298)--
Revision--The National Home and Hospice Care Survey (NHHCS) was 
conducted in 1992, 1993, 1994 and 1996. It is part of the Long-Term 
Care component of the National Health Care Survey. Section 306 of the 
Public Health Service Act states that the National Center for Health 
Statistics ``shall collect statistics on health resources * * * [and] 
utilization of health care, including utilization of * * * services of 
hospitals, extended care facilities, home health agencies, and other 
institutions.'' NHHCS data are used to examine this most rapidly 
expanding

[[Page 57437]]

sector of the health care industry. Data from the NHHCS are widely used 
by the health care industry and policy makers for such diverse analyses 
as the need for various medical supplies; minority access to health 
care; and planning for the health care needs of the elderly. The NHHCS 
also reveals detailed information on utilization patterns, as needed to 
make accurate assessments of the need for and costs associated with 
such care. Data from earlier NHHCS collections have been used by the 
Congressional Budget Office, the Bureau of Health Professions, the 
Maryland Health Resources Planning Commission, the National Association 
for Home Care, and by several newspapers and journals. Additional uses 
are expected to be similar to the uses of the National Nursing Home 
Survey. NHHCS data cover: baseline data on the characteristics of 
hospices and home health agencies in relation to their patients and 
staff, Medicare and Medicaid certification, costs to patients, sources 
of payment, patients' functional status and diagnoses. Data collection 
is planned for the period July-October, 1997. Survey design is in 
process now. Sample selection and preparation of layout forms will 
precede the data collection by several months. The total cost to 
respondents is estimated at $172,500.

----------------------------------------------------------------------------------------------------------------
                                                                             No. of    Avg. burden/     Total   
                        Respondents                             No. of     responses/    response    burden  (in
                                                             respondents   respondent    (in hrs.)      hrs.)   
----------------------------------------------------------------------------------------------------------------
Agency Questionnaire.......................................        1,200            1         0.333          400
Current Patient Sampling List..............................        1,200            1         0.333          400
Current Patient Questionnaire..............................        1,200            6         0.25         1,800
Discharged Patient Sampling List...........................        1,200            1         0.50           600
Discharged Patient Questionnaire...........................        1,200            6         0.25         1,800
                                                            ----------------------------------------------------
      Total................................................                                                5,000
----------------------------------------------------------------------------------------------------------------

    2. Childhood Lead Poisoning Prevention Program Quarterly Report 
(0902-0282)--Extension--Lead poisoning is the most common and 
societally devastating environmental disease of young children in the 
United States. Severe lead exposure can cause coma, convulsions, and 
even death. Lower levels of lead, which rarely cause symptoms, can 
result in decreased intelligence, developmental disabilities, and 
behavioral disturbances. State and community health agencies are the 
principal delivery points for childhood lead screening and related 
medical and environmental management activities. In FY 1996, CDC 
awarded 40 grants to fund childhood lead poisoning prevention programs. 
The primary purpose of these grants is for the initiation or expansion 
of state- and community-based childhood lead poisoning prevention 
programs that do the following: (1) screen infants and children for 
elevated blood lead levels, (2) assure referral for treatment of, and 
environmental intervention for, infants and children with elevated 
blood lead levels, and (3) to provide education about childhood lead 
poisoning. The purpose of the quarterly report is to report data 
collected by CDC's grantees. The report consists of narrative and data 
sections. The purpose of the narrative section is to provide the 
following: (1) highlights of quarterly activities, (2) discuss issues 
and activities that have significant impact on the program, (3) list 
objectives and discuss progress towards meeting those objectives. The 
purpose of the data section is to provide the following: (1) screening 
and case confirmation activities, (2) environmental inspection and 
hazard remediation activities, and (3) medical case management 
activities. The total cost to the respondents is $0.00.

----------------------------------------------------------------------------------------------------------------
                                                                              No. of    Avg. burden/    Total   
                         Respondents                             No. of     responses/    response   burden  (in
                                                              respondents   respondent   (in hrs.)      hrs.)   
----------------------------------------------------------------------------------------------------------------
Grantees....................................................           40            4            2          320
----------------------------------------------------------------------------------------------------------------

    3. Validation of Self-Reported Health Outcomes from the Health 
Assessment of Persian Gulf War Veterans From Iowa--Extension with 
change--The purpose of this proposed study is to collect additional 
data to validate health outcomes reported by participants in the Health 
Assessment of Persian Gulf War Veterans From Iowa. The original data 
collection consisted of a telephone survey of 3,695 military personnel 
who served during the time of the Persian Gulf War and listed Iowa as 
their home of residence. Data will be collected from subjects who 
participated in the telephone survey to validate the self-report of 
four health outcomes: cognitive dysfunction, depression, asthma, and 
multi systemic conditions. Neuropsychological testing will be 
administered to validate cognitive dysfunction. Structured clinical 
interviews for mental disorders and paper-and-pencil questionnaires 
will be administered to validate depression. Lung function assessment, 
tests of airways hyperactivity, and standard respiratory health 
questionnaires will be administered to validate asthma. Review of 
medical records, standard physical examination, and laboratory 
evaluation will be conducted to validate multi systemic conditions, 
including chronic fatigue syndrome and fibromyalgia. In addition, a 
feasibility study will be conducted to explore the usefulness of two 
databases established by the Department of Defense, the Troop Exposure 
Assessment Model and the Registry of Unit Locations, to validate self-
reported exposures among Persian Gulf War veterans who participated in 
the Iowa telephone survey. The total cost to the respondents is $0.00.

[[Page 57438]]



----------------------------------------------------------------------------------------------------------------
                                                                            No. of    Avg. burden/              
                        Respondents                            No. of     responses/  response (in  Total burden
                                                            respondents   respondent      hrs.)       (in hrs.) 
----------------------------------------------------------------------------------------------------------------
                                    Case Validation of Cognitive Dysfunction                                    
                                                                                                                
----------------------------------------------------------------------------------------------------------------
PGW Exposed Veterans with self- reported symptoms of                                                            
 Cognitive Dysfunction. Full neuropsychological exam......          100            1          4.0          400  
Non-PGW Veterans with self-reported symptoms of Cognitive                                                       
 Dysfunction. Full neuropsychological exam................          100            1          4.0          400  
Normal Controls (PGW/Non-PGW Veterans denying symptoms of                                                       
 Cognitive Dysfunction). Cognitive testing................          100            1          2.0          200  
                                                           -----------------------------------------------------
Total.....................................................  ...........  ...........  ............        1000  
                                                                                                                
----------------------------------------------------------------------------------------------------------------
                                           Case Validation for Asthma                                           
                                                                                                                
----------------------------------------------------------------------------------------------------------------
PGW Exposed and Non-PGW Veterans self-reporting asthma.                                                         
 Questionnaire (ATS and Adult Respiratory Health);                                                              
 Pulmonary Function Tests (spirometry, DLCO, lung                                                               
 volumes); Histamine Challenge............................           50            1          2.25         112.5
Normal Controls. (PGW/Non-PGW Vets denying symptoms of                                                          
 asthma). Questionnaire (ATS and Adult Respiratory                                                              
 Health); Pulmonary Function Tests (spirometry, DLCO, lung                                                      
 volumes); Histamine Challenge............................           50            1          2.25         112.5
                                                           -----------------------------------------------------
      Total...............................................  ...........  ...........  ............         225  
                                                                                                                
----------------------------------------------------------------------------------------------------------------
                                         Case Validation of Depression                                          
                                                                                                                
----------------------------------------------------------------------------------------------------------------
PGW Exposed Veterans reporting ``any type of depression.''                                                      
 Questionnaire (Structured Clinical Interview and Family                                                        
 History-Research Diagnostic Criteria)....................           50            1          3.0          150  
Non-PGW Exposed Veterans reporting ``any type of                                                                
 depression.'' Questionnaire (Structured Clinical                                                               
 Interview and Family History-Research Diagnostic                                                               
 Criteria)................................................           50            1          3.0          150  
                                                           -----------------------------------------------------
      Total...............................................  ...........  ...........  ............         300  
                                                                                                                
----------------------------------------------------------------------------------------------------------------
                                     Validation of Multi-Systemic Illnesses                                     
                                                                                                                
----------------------------------------------------------------------------------------------------------------
PGW Exposed and Non-PGW Veterans reporting symptoms of                                                          
 chronic fatigue, fibromyalgia, and/or multiple chemical                                                        
 sensitivity. Iowa Persian Gulf Study Questionnaire;                                                            
 Physical exam............................................          243            1          3.0          729  
Normal Control (PGW/Non-PGW Veterans denying symptoms of                                                        
 chronic fatigue, fibromyalgia, and/or multiple chemical                                                        
 sensitivity). Iowa Persian Gulf Study Questionnaire;                                                           
 Physical exam............................................          116            1          3.0          348  
                                                           -----------------------------------------------------
      Total...............................................  ...........  ...........  ............        1077  
----------------------------------------------------------------------------------------------------------------

Wilma G. Johnson,
Acting Associate Director for Policy Planning and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 96-28502 Filed 11-5-96; 8:45 am]
BILLING CODE 4163-10-P